Shares of Advanced Enzyme Technologies rose 3.14% to trade at Rs 195.30. The stock has traded in the range of Rs 194.40 and Rs 206.85 so far during the day.

Revenues from the animal healthcare segment rose 9% to Rs 12.9 crore while those from the human healthcare segment increased by 7% to Rs 82.4 crore in Q2 September 2019 over Q2 September 2018. The industrial bio-processing segment revenues improved by 13% to Rs 16.1 crore during the stated period.

Consolidated EBITDA rose by 12% to Rs 47.3 crore in Q2 September 2019 as compared to Rs 42.1 crore in the corresponding quarter during last fiscal.

Advanced Enzymes is a research driven company with global leadership in the manufacturing of enzymes. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 25.99% to Rs 11.15 crore in the quarter ended September 2019 as against Rs 8.85 crore during the previous quarter ended September 2018. Sales rose 0.58% to Rs 58.91 crore in the quarter ended September 2019 as against Rs 58.57 crore during the previous quarter ended September 2018.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 23.08% to Rs 31.84 crore in the quarter ended September 2019 as against Rs 25.87 crore during the previous quarter ended September 2018. Sales rose 8.04% to Rs 111.44 crore in the quarter ended September 2019 as against Rs 103.15 crore during the previous quarter ended September 2018.

Powered by Capital Market - Live News

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 2 November 2019.

Powered by Capital Market - Live News